Subcutaneous vedolizumab dose intensification in inflammatory bowel disease patients

the OPTI-VEDO multicenter study from the GETAID

  • Wils, Pauline
  • Altwegg, Romain
  • Buisson, Anthony
  • Vuitton, Lucine
  • Nancey, Stéphane
  • Richard, Nicolas
  • Fumery, Mathurin
  • Bouguen, Guillaume
  • Guillo, Lucas
  • Caron, Bénédicte
  • Duveau, Nicolas
  • Stefanescu, Carmen
  • Pelletier, Anne-Laure
  • Reenaers, Catherine
  • Gilletta, Cyrielle
  • Uzzan, Mathieu
  • Arab, Nadia
  • Laharie, David
  • Vidon, Mathias
  • Amiot, Aurelien
  • Le Berre, Catherine
  • Kirchgesner, Julien
  • Dewit, Olivier
  • Simon, Marion
  • Goutorbe, Félix
  • Vicaut, Eric
  • Peyrin-Biroulet, Laurent
Journal of Crohn's and Colitis Publish Ahead of Print, September 10, 2025. | DOI: 10.1093/ecco-jcc/jjaf166
Copyright © 2015 European Crohn's and Colitis Organisation (ECCO). Published by Oxford University Press.